GC Holdings Sells Curevo Stake for 459.9B KRW
녹십자홀딩스
005250
Signal Score
Historical Avg Return (5d)
+0.67%
Data Coverage
44%n=133
Risk-adjusted indicator based on 133 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Disposal Amount: 459,926,415,106 KRW
- • Number of Shares Disposed: 21,075,336 Shares
3 more figures — Starter & Pro plans
AI Analysis Summary
Green Cross Holdings' subsidiary, GC Biopharma Corp., decided to dispose of its entire stake in Curevo, Inc., a US-based medical R&D company, to Eli Lilly and Company for 459.9 billion KRW. This disposal, representing 15.48% of GC Biopharma's total assets and approximately 11.30% of Green Cross Holdings' consolidated total assets, aims to secure funds for new business investments. Curevo, Inc. reported a net loss of 63.3 billion KRW in 2025. The transaction is structured with upfront and milestone payments, with the disposal expected to be completed by August 24, 2026. This move is expected to improve the financial structure and provide capital for future growth initiatives.
Risk Factors
Pro plan
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Price reaction & historical pattern data
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.